Ardea Biosciences, Inc. (NASDAQ: RDEA), headquartered in San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer, inflammatory diseases and human immunodeficiency virus (HIV).

Webcasts
Piper Jaffray 4th Annual Europe Conference Tuesday, June 23, 2009, 4:00pm BST London

Latest News and Press Releases

To Review All Press Releases click here